Bioequivalence of Single Dose Phenylephrine Extended Release Tablets and Phenylephrine HCl Immediate Release Tablets Dosed Every Four Hours (P08340)(COMPLETED)

• Status: Completed
• Trial end date: 2011-07-01

Summary

This study will assess the food-effect bioavailability of an extended release formulation of phenylephrine HCl and its bioequivalence to the marketed immediate release phenylephrine HCl product.

• Phase: Phase 1

Details

• Lead Sponsor: Bayer
• Treatments: Oxymetazoline; Phenylephrine